BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17691073)

  • 21. Interfacial recognition by bee venom phospholipase A2: insights into nonelectrostatic molecular determinants by charge reversal mutagenesis.
    Ghomashchi F; Lin Y; Hixon MS; Yu BZ; Annand R; Jain MK; Gelb MH
    Biochemistry; 1998 May; 37(19):6697-710. PubMed ID: 9578553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity.
    Jameel NM; Shekhar MA; Vishwanath BS
    Life Sci; 2006 Dec; 80(2):146-53. PubMed ID: 17011589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
    De Rosa M; Giordano S; Scettri A; Sodano G; Soriente A; Pastor PG; Alcaraz MJ; Payá M
    J Med Chem; 1998 Aug; 41(17):3232-8. PubMed ID: 9703468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.
    Glaser KB; Jacobs RS
    Biochem Pharmacol; 1986 Feb; 35(3):449-53. PubMed ID: 3947381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein.
    Emmerling MR; Moore CJ; Doyle PD; Carroll RT; Davis RE
    Biochem Biophys Res Commun; 1993 Nov; 197(1):292-7. PubMed ID: 8250938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
    Glaser KB; de Carvalho MS; Jacobs RS; Kernan MR; Faulkner DJ
    Mol Pharmacol; 1989 Nov; 36(5):782-8. PubMed ID: 2586492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products. Sponges to wipe away pain.
    Mann J
    Nature; 1992 Aug; 358(6387):540. PubMed ID: 1501709
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.
    Reynolds LJ; Mihelich ED; Dennis EA
    J Biol Chem; 1991 Sep; 266(25):16512-7. PubMed ID: 1885583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group V phospholipase A2-derived lysophosphatidylcholine mediates cyclooxygenase-2 induction in lipopolysaccharide-stimulated macrophages.
    Ruipérez V; Casas J; Balboa MA; Balsinde J
    J Immunol; 2007 Jul; 179(1):631-8. PubMed ID: 17579085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1.
    Thommesen L; Sjursen W; Gåsvik K; Hanssen W; Brekke OL; Skattebøl L; Holmeide AK; Espevik T; Johansen B; Laegreid A
    J Immunol; 1998 Oct; 161(7):3421-30. PubMed ID: 9759860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLA2 inhibitory activity of marine sesterterpenoids cladocorans, their diastereomers and analogues.
    Miyaoka H; Yamanishi M; Mitome H
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):268-70. PubMed ID: 16462082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of manoalide on secreted and intracellular phospholipases.
    Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST
    Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipase A2 inhibitors from marine organisms.
    Potts BC; Faulkner DJ; Jacobs RS
    J Nat Prod; 1992 Dec; 55(12):1701-17. PubMed ID: 1294693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular model of the interaction of bee venom phospholipase A2 with manoalide.
    Ortiz AR; Pisabarro MT; Gago F
    J Med Chem; 1993 Jun; 36(13):1866-79. PubMed ID: 8515424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Manoalide: a new phospholipase A2 inhibitor of marine origin with potential immunoregulatory effect].
    Mayer AM
    Medicina (B Aires); 1989; 49(2):175-80. PubMed ID: 2640487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and inhibitory profile of phospholipase A2 inhibitors from Australian elapid sera.
    Hains PG; Broady KW
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):139-46. PubMed ID: 10657250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In cell scalaradial interactome profiling using a bio-orthogonal clickable probe.
    Cassiano C; Margarucci L; Esposito R; Riccio R; Tosco A; Casapullo A; Monti MC
    Chem Commun (Camb); 2014 Jun; 50(45):6043-5. PubMed ID: 24769547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLA2-mediated catalytic activation of its inhibitor 25-acetyl-petrosaspongiolide M: serendipitous identification of a new PLA2 suicide inhibitor.
    Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
    FEBS Lett; 2004 Dec; 578(3):269-74. PubMed ID: 15589831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scalaradial Is a Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels.
    Starkus JG; Poerzgen P; Layugan K; Kawabata KG; Goto JI; Suzuki S; Myers G; Kelly M; Penner R; Fleig A; Horgen FD
    J Nat Prod; 2017 Oct; 80(10):2741-2750. PubMed ID: 29019677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.